Generic medicines form a major part of Iran’s pharmaceutical industry and play a vital role in providing broad, affordable, and sustainable access to essential medicines for the population.

Iran has strong capabilities in formulating and producing generic drugs that meet international standards. Many domestic pharmaceutical companies use modern technologies to manufacture high-quality generics with comparable efficacy and safety to branded alternatives.

Generic drugs offer significantly lower production costs compared to branded medicines, helping reduce healthcare expenses and easing the financial burden on the national health system. Their production also supports industrial growth and creates skilled employment opportunities.

Iran exports generic pharmaceuticals to neighboring countries and various Asian and African markets. Competitive pricing, reliable quality, and the ability to supply in large volumes contribute to their success in international markets.

Iran’s competitive advantages include strong technical expertise, a highly trained workforce, large-scale production capacity, low manufacturing costs, and long-standing experience in generics manufacturing. Gaining international certifications and improving packaging and marketing strategies can further enhance Iran’s competitiveness in global generic drug markets.